An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
A Man Has Received the First Pig-Kidney Transplant
- blkalertshealth
- March 22, 2024
- 0
The first reported person in the world ha
Hamas releases new hostage video, includes American captive
- blkalertshealth
- April 28, 2024
- 0
Hamas released new footage of hostages on Saturday
Feeling stuck? How to find or reignite your life’s purpose
- blkalertshealth
- April 18, 2024
- 0
If you’re feeling stuck in a rut, there are